| 101 | CHEChemed Corp |
2,5 mld USD |
10,5% |
2025 |
| 102 | TDOCTeladoc Health, Inc. |
2,5 mld USD |
-7,9% |
2025 |
| 103 | AVAHAveanna Healthcare Holdings, Inc. |
2,4 mld USD |
9,2% |
2026 |
| 104 | RPRXRoyalty Pharma plc |
2,4 mld USD |
32,4% |
2025 |
| 105 | HIMSHims & Hers Health, Inc. |
2,3 mld USD |
5,5% |
2025 |
| 106 | EXELExelixis, Inc. |
2,3 mld USD |
33,7% |
2025 |
| 107 | NTRANatera, Inc. |
2,3 mld USD |
-9,0% |
2025 |
| 108 | ENOVEnovis CORP |
2,2 mld USD |
-52,7% |
2025 |
| 109 | ICUIIcu Medical Inc |
2,2 mld USD |
0,0% |
2025 |
| 110 | SRPTSarepta Therapeutics, Inc. |
2,2 mld USD |
-32,5% |
2025 |
| 111 | CONConcentra Group Holdings Parent, Inc. |
2,2 mld USD |
7,7% |
2025 |
| 112 | PRVAPrivia Health Group, Inc. |
2,1 mld USD |
1,1% |
2025 |
| 113 | QGENQiagen N.V. |
2,1 mld USD |
20,3% |
2025 |
| 114 | RDNTRadNet, Inc. |
2 mld USD |
-0,9% |
2025 |
| 115 | TFXTeleflex Inc |
2 mld USD |
-45,4% |
2025 |
| 116 | EYENational Vision Holdings, Inc. |
2 mld USD |
1,5% |
2025 |
| 117 | MRNAModerna, Inc. |
1,9 mld USD |
-145,2% |
2025 |
| 118 | CLOVClover Health Investments, Corp. |
1,9 mld USD |
-4,4% |
2025 |
| 119 | MDPediatrix Medical Group, Inc. |
1,9 mld USD |
8,6% |
2025 |
| 120 | MSAMSA Safety Inc |
1,9 mld USD |
14,9% |
2025 |
| 121 | ITGRInteger Holdings Corp |
1,9 mld USD |
5,5% |
2025 |
| 122 | HCSGHealthcare Services Group Inc |
1,8 mld USD |
3,2% |
2025 |
| 123 | PTCTPtc Therapeutics, Inc. |
1,7 mld USD |
39,4% |
2025 |
| 124 | IARTIntegra Lifesciences Holdings Corp |
1,6 mld USD |
-31,6% |
2025 |
| 125 | LNTHLantheus Holdings, Inc. |
1,5 mld USD |
15,2% |
2025 |
| 126 | PAHCPhibro Animal Health Corp |
1,5 mld USD |
6,6% |
2026 |
| 127 | NHCNational Healthcare Corp |
1,5 mld USD |
7,9% |
2025 |
| 128 | MMSIMerit Medical Systems Inc |
1,5 mld USD |
8,5% |
2025 |
| 129 | NUSNU Skin Enterprises, Inc. |
1,5 mld USD |
10,8% |
2025 |
| 130 | ALKSAlkermes plc. |
1,5 mld USD |
16,4% |
2025 |
| 131 | PIIIP3 Health Partners Inc. |
1,5 mld USD |
-10,1% |
2024 |
| 132 | TRUPTrupanion, Inc. |
1,4 mld USD |
1,4% |
2025 |
| 133 | LFSTLifeStance Health Group, Inc. |
1,4 mld USD |
0,7% |
2025 |
| 134 | ADUSAddus HomeCare Corp |
1,4 mld USD |
6,7% |
2025 |
| 135 | PENPenumbra Inc |
1,4 mld USD |
12,7% |
2025 |
| 136 | HALOHalozyme Therapeutics, Inc. |
1,4 mld USD |
22,7% |
2025 |
| 137 | LIVNLivaNova PLC |
1,4 mld USD |
-17,5% |
2025 |
| 138 | CNMDCONMED Corp |
1,4 mld USD |
3,4% |
2025 |
| 139 | HAEHaemonetics Corp |
1,3 mld USD |
7,3% |
2026 |
| 140 | PGNYProgyny, Inc. |
1,3 mld USD |
4,5% |
2025 |
| 141 | CURLFCuraleaf Holdings, Inc. |
1,3 mld USD |
-18,2% |
2025 |
| 142 | INDVIndivior Pharmaceuticals, Inc. |
1,2 mld USD |
16,9% |
2025 |
| 143 | NSRXNasus Pharma Ltd |
1,2 mld USD |
-0,5% |
2025 |
| 144 | TECHBIO-TECHNE Corp |
1,2 mld USD |
15,0% |
2026 |
| 145 | TRLVTrulieve Cannabis Corp. |
1,2 mld USD |
-9,9% |
2025 |
| 146 | SHCSotera Health Co |
1,2 mld USD |
6,7% |
2025 |
| 147 | NVAXNovavax Inc |
1,1 mld USD |
39,2% |
2025 |
| 148 | PBHPrestige Consumer Healthcare Inc. |
1,1 mld USD |
17,5% |
2026 |
| 149 | EMBCEmbecta Corp. |
1,1 mld USD |
8,8% |
2025 |
| 150 | ACADAcadia Pharmaceuticals Inc |
1,1 mld USD |
36,5% |
2025 |